Lower risk for heart failure with new type 2 diabetes drug

The new type of drugs for type 2 diabetes, the so-called SGLT2 inhibitors, are associated with a reduced risk of heart failure and death as well as of major cardiovascular events, a major Scandinavian registry study reports.

Leave a Reply

Your email address will not be published. Required fields are marked *